News & Insights

Renellence Confirmed as Exclusive Canadian Home for saypha®

Toronto, Canada – January 22, 2026 – Renellence Inc. is pleased to confirm its status as the exclusive authorized distributor of saypha® dermal fillers in Canada. Following the conclusion of Croma-Pharma’s distribution arrangement with Hugel, Renellence has assumed full responsibility for the sales, logistical support, and clinical education for the saypha® portfolio across the country.


Renellence now assumes responsibility for the distribution and ongoing support of saypha products in Canada, ensuring continued access for healthcare professionals and a smooth transition in service.


saypha products now carry MDR certification with updated packaging, confirming compliance with the European Union's Medical Device Regulation, a rigorous framework ensuring safety, performance, and quality standards for medical devices across regulated markets.

To prevent any disruption in supply, current saypha® accounts should contact Renellence immediately to update their vendor records. Our onboarding team is ready to facilitate a seamless transition for your clinic.

Back to news